GLP‑1 weight‑loss drugs may reduce biological age by 2‑3 years in overweight and diabetic patients. Research presented at an aging meeting in Boston shows these medications lower biological age markers, hinting at potential longevity benefits and new therapeutic uses for GLP‑1 therapies.
Opening Kapyn…